You are here:

MS in the media - 15 July 2016

Published on

9 - 15 July 2016

These are links to news stories from the last fortnight that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.

Disease modifying drugs and cognition

A year long study comparing Gilenya (fingolimod) and Tysabri (natalizumab) found that the drugs produced a similar effect on reducing the build-up of cognitive problems

Source: MS News Today

MS Trust link: MS Decisions - a guide to the disease modifying drugs
MS Trust link: Cognition and cognitive symptoms

New measure for person-centred care

The Patient Activation Measure (PAM) is to be rolled out to 37 areas of England over the next five years to measure how engaged and confident people with long-term conditions feel in taking care of their health and wellbeing

Source: NHS England

MS Trust link: Lifestyle

Print this page